GlassScriptPhysician profile
Kunal Sangal
NPI 1679910350
$8,313.87
in general payments reported to CMS, 2019-2025
29 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.21 · 2020: $537 · 2021: $1,365 · 2022: $3,077 · 2023: $599 · 2024: $929 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,283.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,416.15 | 2020-2025 | Impella |
| Medtronic, INC. | $1,363.21 | 2021-2022 | |
| Edwards Lifesciences Corporation | $1,229.04 | 2021-2022 | |
| Abbott Laboratories | $1,085.08 | 2020-2024 | Optis, Dragonfly Opstar, Mitraclip |
| Boston Scientific Corporation | $921.42 | 2021-2025 | General - Stents, Avvigo Guidance System, General - Balloon Catheters |
| Penumbra, INC. | $391.11 | 2023-2025 | Indigo System, Penumbra System |
| Philips North America LLC | $344.72 | 2023-2025 | Coronary Undivided, Mcot, (Bq9) Coronary Ivus |
| Astrazeneca Pharmaceuticals LP | $182.72 | 2019-2024 | Farxiga, Andexxa |
| Shockwave Medical, INC | $171.41 | 2025 | |
| Chiesi USA, INC. | $145.59 | 2021-2023 | Kengreal |
| Asahi Intecc USA, INC. | $125.33 | 2020-2024 | Peripheral Vascular |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Medtronic Vascular, INC. | $100.35 | 2020 | |
| W. L. Gore & Associates, INC. | $95.22 | 2022-2024 | Gore Cardioform Septal Occluder |
| Amgen INC. | $94.28 | 2023-2025 | Repatha, Repatha |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $84.29 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $64.96 | 2023-2025 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $54.35 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.85 | 2019-2023 | Lifevest |
| Cvrx, INC. | $45.57 | 2024 | Barostim Neo System |
| Stryker Corporation | $43.32 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $41.11 | 2020-2021 | |
| Angiodynamics, INC. | $38.88 | 2025 | Alphavac |
| Irhythm Technologies, INC. | $23.63 | 2022 | |
| Baxter Healthcare | $20.05 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $17.71 | 2024 | |
| Pfizer INC. | $16.42 | 2021 | |
| Daiichi Sankyo INC. | $15.97 | 2025 | Injectafer |
| Lantheus Medical Imaging, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Sangal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.